MED (Medifast) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


MED Medifast Inc MED
69 GF Score
Price $10.36
GF Value $8.75
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Medifast's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

MED vs RGS, VGES, EVTK: Margin of Safety % (DCF Earnings Based) Comparison

For the Personal Services subindustry, Medifast's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medifast Margin of Safety % (DCF Earnings Based) vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Medifast's Margin of Safety % (DCF Earnings Based) falls into.


MED
69GF Score
Medifast Inc MED
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medifast (MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of $10.36 is trading 18.4% above its estimated GF Value™ of $8.75. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for MED:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $8.75 vs. price of $10.36 (18.4% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medifast Business Description

Other Exchanges 0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score

Get the complete analysis for MED

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.36
Price
$8.75
GF Value